Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Prisant, M. Weber, H. Black (2005)
Chronotherapeutic oral drug absorption system verapamil is effective in reducing morning blood pressure in African Americans: a post hoc analysis of the chrono trial.Journal of the National Medical Association, 97 3
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel Jones, B. Materson, S. Oparil, J. Wright, E. Roccella (2003)
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.Hypertension, 42 6
(2008)
Hypertension in America: estimates for the US civilian noninstitutionalized population, age 18 and older
R. Cooper-DeHoff, Qian Zhou, E. Gaxiola, J. Cangiano, D. García-Barreto, E. Handberg, C. Pepine (2007)
Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST.Journal of women's health, 16 5
David Smith, B. Bradshaw (2006)
Rethinking the Hispanic paradox: death rates and life expectancy for US non-Hispanic White and Hispanic populations.American journal of public health, 96 9
(2011)
Surveillance of health status in minority communities-Racial and Ethnic Approaches to Community Health Across the U.S(REACH U.S.) Risk Factor Survey, United States, 2009. MMWR Surveill Summ, 60
H. Black, A. Kribben, F. Palacios, M. Bijarnia, A. Laflamme, F. Baschiera (2010)
Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double‐Blind StudyThe Journal of Clinical Hypertension, 12
E. Ofili, S. Oparil, T. Giles, B. Pitt, D. Purkayastha, R. Hilkert, R. Samuel, J. Sowers (2011)
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups.Journal of the American Society of Hypertension : JASH, 5 4
A. Whaley‐Connell, D. Purkayastha, A. Yadao, J. Sowers (2011)
Central Pressure and Biomarker Responses to Renin Inhibition with Hydrochlorothiazide and Ramipril in Obese Hypertensives: The ATTAIN StudyCardiorenal Medicine, 1
G. Mancia, G. Backer, A. Dominiczak, R. Cífková, R. Fagard, G. Germano, G. Grassi, A. Heagerty, S. Kjeldsen, S. Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R. Schmieder, H. Boudier, A. Zanchetti (2007)
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Journal of Hypertension, 25
(2010)
Ethnic differences in response to combination aliskiren/HCTZ vs ramipril monotherapy in obese patients with stage 2 hypertension [abstract PO-67
Va, CHAMPVA1 Medicaid, Medicare, U. u (2002)
Health Insurance Coverage in the United States
(2004)
Evaluation of mortality data for older Mexican Americans: implications for the Hispanic paradoxAm J Epidemiol, 159
G. Mensah, W. Dietz, V. Harris, R. Henson, D. Labarthe, F. Vinicor, H. Wechsler (2005)
Prevention and control of coronary heart disease and stroke--nomenclature for prevention approaches in public health: a statement for public health practice from the Centers for Disease Control and Prevention.American journal of preventive medicine, 29 5 Suppl 1
Rodolfo Gutiérrez-Solana (1999)
Espinosa de los Monteros
(DeNavas-Walt C, Proctor BD, Smith JC. U.S. Census Bureau, Current Population Reports, P60–238, Income, Poverty, and Health Insurance Coverage in the United States: 2009, U.S. Government Printing Office, Washington, DC: 2010)
DeNavas-Walt C, Proctor BD, Smith JC. U.S. Census Bureau, Current Population Reports, P60–238, Income, Poverty, and Health Insurance Coverage in the United States: 2009, U.S. Government Printing Office, Washington, DC: 2010DeNavas-Walt C, Proctor BD, Smith JC. U.S. Census Bureau, Current Population Reports, P60–238, Income, Poverty, and Health Insurance Coverage in the United States: 2009, U.S. Government Printing Office, Washington, DC: 2010, DeNavas-Walt C, Proctor BD, Smith JC. U.S. Census Bureau, Current Population Reports, P60–238, Income, Poverty, and Health Insurance Coverage in the United States: 2009, U.S. Government Printing Office, Washington, DC: 2010
Y. Liao, David Bang, Shannon Cosgrove, Rick Dulin, Zachery Harris, April Taylor, Shannon White, Graydon Yatabe, L. Liburd, W. Giles (2011)
Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.Morbidity and mortality weekly report. Surveillance summaries, 60 6
A. Bersamin, R. Stafford, M. Winkleby (2009)
Predictors of Hypertension Awareness, Treatment, and Control Among Mexican American Women and MenJournal of General Internal Medicine, 24
(2007)
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J, 28
K. Hunt, Roy Resendez, K. Williams, S. Haffner, M. Stern, H. Hazuda (2003)
All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox".American journal of epidemiology, 158 11
L. Franzini, J. Ribble, A. Keddie (2001)
Understanding the Hispanic paradox.Ethnicity & disease, 11 3
R. Vivo, S. Krim, C. Çevik, R. Witteles (2009)
Heart failure in Hispanics.Journal of the American College of Cardiology, 53 14
Nicole Redmond, H. Baer, L. Hicks (2011)
Health Behaviors and Racial Disparity in Blood Pressure Control in the National Health and Nutrition Examination SurveyHypertension, 57
A. Whaley‐Connell, B. Pavey, P. McCullough, G. Saab, Suying Li, Samy McFarlane, Shu‐Cheng Chen, J. Vassalotti, A. Collins, G. Bakris, J. Sowers (2010)
Dysglycemia Predicts Cardiovascular and Kidney Disease in the Kidney Early Evaluation ProgramThe Journal of Clinical Hypertension, 12
Giuseppe Mancia, G. Backer, A. Dominiczak, R. Cífková, R. Fagard, Giuseppe Germanò, Guido Grassi, A. Heagerty, S. Kjeldsen, Stéphane Laurent, K. Narkiewicz, L. Ruilope, A. Rynkiewicz, R. Schmieder, H. Boudier, A. Zanchetti, A. Vahanian, John Camm, R. Caterina, V. Dean, Kenneth Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, Petr Widimsky, J. Zamorano, S. Erdine, Wolfgang Kiowski, Enrico Agabiti-Rosei, E. Ambrosioni, Lars Lindholm, A. Manolis, Peter Nilsson, Josep Redon, H. Struijker-Boudier, M. Viigimaa, S. Adamopoulos, V. Bertoméu, Denis Clement, Csaba Farsang, D. Gaita, G. Lip, J. Mallion, Eoin O'Brien, Piotr Ponikowski, F. Ruschitzka, J. Tamargo, P. Zwieten, Bernard Waeber, Bryan Williams (2007)
2007 Guidelines for the management of arterial hypertensionEuropean Heart Journal, 28
(2011)
Combination direct renin inhibitor/calcium channel blocker with or without diuretic effectively lowers blood pressure (BP) in Hispanic patients with stage 2 hypertension: a subgroup analysis of the aliksiren+amlodipine±HCTZ in minority patients with stage 2 hypertension (ASCENT) study [abstract P174]Hypertension, 58
K. Hershon (2011)
Mechanistic and clinical aspects of renin-angiotensin-aldosterone system blockade in the prevention of diabetes mellitus and cardiovascular disease.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 17 3
(2010)
Aliskiren alone or in combination with hydrochlorothiazide lowers BP effectively in Hispanic/Latino patients with systolic BP 160-<180mm Hg (AQUIRE study) [abstract PO-16
J. D'Elia, G. Bayliss, B. Roshan, Manish Maski, R. Gleason, L. Weinrauch (2010)
Diabetic microvascular complications: possible targets for improved macrovascular outcomesInternational Journal of Nephrology and Renovascular Disease, 4
E. Ofili, G. Cable, J. Neutel, E. Saunders (2008)
Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.Journal of women's health, 17 6
H. Punzi, A. Lewin, T. Lukić, T. Goodin, Wei Chen (2010)
Efficacy and safety of nebivolol in Hispanics with stage I-II hypertension: a randomized placebo-controlled trialTherapeutic Advances in Cardiovascular Disease, 4
P. Sorlie, E. Backlund, N. Johnson, E. Rogot (1993)
Mortality by Hispanic status in the United States.JAMA, 270 20
V. Dias, B. Tendler, S. Oparil, P. Reilly, P. Snarr, W. White (1999)
Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics.American journal of therapeutics, 6 1
Luis Rustveld, V. Pavlik, Maria Jibaja-Weiss, K. Kline, Travis Gossey, R. Volk (2009)
Adherence to diabetes self-care behaviors in English- and Spanish-speaking Hispanic menPatient preference and adherence, 3
Linda Gallo, F. Penedo, Karla Monteros, W. Arguelles (2009)
Resiliency in the face of disadvantage: do Hispanic cultural characteristics protect health outcomes?Journal of personality, 77 6
DeNavas-Walt Carmen, Bernadette Proctor, Jessica Smith (2008)
Current Population Reports, P60-235, Income, Poverty, and Health Insurance Coverage in the United States: 2007
Ana Traylor, J. Schmittdiel, Connie Uratsu, C. Mangione, U. Subramanian (2010)
Adherence to Cardiovascular Disease Medications: Does Patient-Provider Race/Ethnicity and Language Concordance Matter?Journal of General Internal Medicine, 25
K. Patel, K. Eschbach, L. Ray, K. Markides (2004)
Evaluation of mortality data for older Mexican Americans: implications for the Hispanic paradox.American journal of epidemiology, 159 7
Rosenberg Hm, Maurer Jd, Paul Sorlie, Johnson Nj, M. MacDorman, D. Hoyert, Spitler Jf, C. Scott (1999)
Quality of death rates by race and Hispanic origin: a summary of current research, 1999.Vital and health statistics. Series 2, Data evaluation and methods research, 128
R. Phillips, R. Kloner, R. Grimm, M. Weinberger (2003)
The Effects of Amlodipine Compared to Losartan in Patients With Mild to Moderately Severe HypertensionThe Journal of Clinical Hypertension, 5
K. Margolis, L. Piller, C. Ford, Mario Henriquez, W. Cushman, P. Einhorn, Pedro Colon, D. Vidt, R. Christian, N. Wong, J. Wright, D. Goff (2007)
Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialHypertension, 50
C. Francis, J. Alpert, L. Clark, E. Ofili, Richard Wong (2004)
Working group 3: How to encourage more minorities to choose a career in cardiology.Journal of the American College of Cardiology, 44 2
Matthew Weir, S. Chrysant, David McCarron, M. Canossa-Terris, J. Cohen, Patricia Gunter, Andrew Lewin, Robert Mennella, Lance Kirkegaard, Jennifer Hamilton, Myron Weinberger, A. Weder (1998)
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.Hypertension, 31 5
(2011)
Available from URL: http://www.census.gov/population/www/socdemo/hispanic/files/Internet_ Hispanic_in_US_2006
(Carroll W. Hypertension in America: estimates for the US civilian non-institutionalized population, age 18 and older, 2008. Agency for Healthcare Research and Quality, Rockville, MD [online]. Available from URL: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st315/stat315.shtml [Accessed 2011 Aug 17])
Carroll W. Hypertension in America: estimates for the US civilian non-institutionalized population, age 18 and older, 2008. Agency for Healthcare Research and Quality, Rockville, MD [online]. Available from URL: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st315/stat315.shtml [Accessed 2011 Aug 17]Carroll W. Hypertension in America: estimates for the US civilian non-institutionalized population, age 18 and older, 2008. Agency for Healthcare Research and Quality, Rockville, MD [online]. Available from URL: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st315/stat315.shtml [Accessed 2011 Aug 17], Carroll W. Hypertension in America: estimates for the US civilian non-institutionalized population, age 18 and older, 2008. Agency for Healthcare Research and Quality, Rockville, MD [online]. Available from URL: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st315/stat315.shtml [Accessed 2011 Aug 17]
A. Carson, G. Howard, G. Burke, S. Shea, E. Levitan, P. Muntner (2011)
Ethnic Differences in Hypertension Incidence Among Middle-Aged and Older Adults: The Multi-Ethnic Study of AtherosclerosisHypertension, 57
N. Keenan, K. Shaw (2011)
Coronary heart disease and stroke deaths - United States, 2006.MMWR supplements, 60 1
Youfa Wang, M. Beydoun, L. Liang, B. Caballero, S. Kumanyika (2008)
Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity EpidemicObesity, 16
R. Cooper-DeHoff, J. Aranda, E. Gaxiola, J. Cangiano, D. García-Barreto, C. Conti, Ann Hewkin, C. Pepine (2006)
Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).American heart journal, 151 5
(Differences in prevalence of obesity among black, white, and Hispanic adults —United States, 2006–2008. MMWR Morb Mortal Wkly Rep 2009; 58: 740–4)
Differences in prevalence of obesity among black, white, and Hispanic adults —United States, 2006–2008. MMWR Morb Mortal Wkly Rep 2009; 58: 740–4Differences in prevalence of obesity among black, white, and Hispanic adults —United States, 2006–2008. MMWR Morb Mortal Wkly Rep 2009; 58: 740–4, Differences in prevalence of obesity among black, white, and Hispanic adults —United States, 2006–2008. MMWR Morb Mortal Wkly Rep 2009; 58: 740–4
K. Ferdinand, R. Weitzman, M. Israel, J. Lee, D. Purkayastha, E. Jaimes (2011)
Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension.Journal of the American Society of Hypertension : JASH, 5 2
Joan Moore, H. Pachon (1985)
Hispanics in the United States
W. Hsueh, K. Wyne (2011)
Renin‐Angiotensin‐Aldosterone System in Diabetes and HypertensionThe Journal of Clinical Hypertension, 13
(Hypertension-related mortality among Hispanic subpopulations — United States, 1995–2002. MMWR Morb Mortal Wkly Rep 2006; 55: 177–80)
Hypertension-related mortality among Hispanic subpopulations — United States, 1995–2002. MMWR Morb Mortal Wkly Rep 2006; 55: 177–80Hypertension-related mortality among Hispanic subpopulations — United States, 1995–2002. MMWR Morb Mortal Wkly Rep 2006; 55: 177–80, Hypertension-related mortality among Hispanic subpopulations — United States, 1995–2002. MMWR Morb Mortal Wkly Rep 2006; 55: 177–80
(Hispanics in the United States. US Census Bureau [online]. Available from URL: http://www.census.gov/population/www/socdemo/hispanic/files/Internet_Hispanic_in_US_2006.pdf [Accessed 2011 Aug 17])
Hispanics in the United States. US Census Bureau [online]. Available from URL: http://www.census.gov/population/www/socdemo/hispanic/files/Internet_Hispanic_in_US_2006.pdf [Accessed 2011 Aug 17]Hispanics in the United States. US Census Bureau [online]. Available from URL: http://www.census.gov/population/www/socdemo/hispanic/files/Internet_Hispanic_in_US_2006.pdf [Accessed 2011 Aug 17], Hispanics in the United States. US Census Bureau [online]. Available from URL: http://www.census.gov/population/www/socdemo/hispanic/files/Internet_Hispanic_in_US_2006.pdf [Accessed 2011 Aug 17]
(2012)
E-mail: nguzman@mfa.gwu.edu 178 Guzman Adis ª All rights reserved
H. Bahrami, R. Kronmal, D. Bluemke, Jean Olson, S. Shea, Kiang Liu, G. Burke, J. Lima (2008)
Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.Archives of internal medicine, 168 19
Y. Uresin, Addison Taylor, C. Kilo, D. Tschöpe, M. Santonastaso, G. Ibram, Hui Fang, A. Satlin (2007)
Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertensionJournal of the Renin-Angiotensin-Aldosterone System, 8
Carmen DeNavas-Walt, Bernadette Proctor, Jessica Smith, Lillian Pecoraro, Trudi Renwick, C. Nelson, D. Benton, K. Davis (2009)
Income, poverty, and health insurance coverage in the United States, 2008.
H. Lauritzen, H. Galbo, Taro Toyoda, L. Goodyear (2010)
Kinetics of Contraction-Induced GLUT4 Translocation in Skeletal Muscle Fibers From Living MiceDiabetes, 59
E. Ofili, K. Ferdinand, E. Saunders, J. Neutel, G. Bakris, W. Cushman, J. Sowers, M. Weber (2006)
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.Journal of the National Medical Association, 98 4
C. Gillespie, Charles Wigington, Yuling Hong (2013)
Coronary heart disease and stroke deaths - United States, 2009.MMWR supplements, 62 3
J. Flack, D. Sica, G. Bakris, Angela Brown, K. Ferdinand, R. Grimm, Wendell Jones, D. Kountz, J. Lea, Samar Nasser, S. Nesbitt, E. Saunders, M. Scisney-Matlock, K. Jamerson (2010)
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.Hypertension, 56 5
Brendan Everett, R. Glynn, E. Danielson, P. Ridker (2008)
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.Clinical therapeutics, 30 4
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel Jones, B. Materson, S. Oparil, J. Wright, E. Roccella (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA, 289 19
S. Harris, Celina Alvarez (1997)
α2-AGONIST VERSUS α1-ANTAGONIST IN MILD‐TO-MODERATE HYPERTENSION: COMPARISON OF TRANSDERMAL CLONIDINE AND TERAZOSIN MONOTHERAPIESAmerican Journal of Therapeutics, 4
P. Eamranond, C. Wee, A. Legedza, E. Marcantonio, Suzanne Leveille (2009)
Acculturation and Cardiovascular Risk Factor Control among Hispanic Adults in the United StatesPublic Health Reports, 124
Director of Outpatient Clinics, The George Washington University Medical Faculty Associates, Division of Renal Diseases and Hypertension, 2150 Pennsylvania Avenue NW, Suite 3-425
A. Abraído-Lanza, M. Chao, K. Flórez (2005)
Do healthy behaviors decline with greater acculturation? Implications for the Latino mortality paradox.Social science & medicine, 61 6
K. Hunt, K. Williams, Roy Resendez, H. Hazuda, S. Haffner, M. Stern (2002)
All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox".Diabetes care, 25 9
(2010)
Efficacy and safety of combination olmesartan medoxomil (OM)+amlodipine besylate (AML)+hydrochlorothiazide (HCTZ): a subgroup analysis by ethnicity and BMI [abstract 2134-PO
Ina Park, Anne Taylor (2007)
Race and Ethnicity in Trials of Antihypertensive Therapy to Prevent Cardiovascular Outcomes: A Systematic ReviewThe Annals of Family Medicine, 5
M. Stern, M. Wei (1999)
Do Mexican Americans really have low rates of cardiovascular disease?Preventive medicine, 29 6 Pt 2
S. Oparil, M. Melino, James Lee, Victor Fernandez, R. Heyrman (2010)
Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.Clinical therapeutics, 32 7
G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak, M. Galderisi, D. Grobbee, T. Jaarsma, P. Kirchhof, S. Kjeldsen, S. Laurent, A. Manolis, P. Nilsson, L. Ruilope, R. Schmieder, P. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad (2007)
2013 ESH/ESC Guidelines for the management of arterial hypertensionBlood Pressure, 22
L. Pan, D. Galuska, B. Sherry, A. Hunter, G. Rutledge, W. Dietz, L. Balluz (2009)
Differences in prevalence of obesity among black, white, and Hispanic adults - United States, 2006-2008.MMWR. Morbidity and mortality weekly report, 58 27
N. Fuenmayor, B. Faggin, L. Cubeddu (1989)
Comparative Efficacy, Safety, and Kinetics of Immediate‐and Slow‐Release Verapamil in Hispanic Patients with Essential HypertensionJournal of Cardiovascular Pharmacology, 13
H. Black, W. Elliott, M. Weber, W. Frishman, J. Strom, P. Liebson, C. Hwang, D. Ruff, R. Montoro, V. Dequattro, Danyi Zhang, M. Schleman, M. Klibaner (2001)
One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic HypertensionHypertension: Journal of the American Heart Association, 38
J. Gardin, Zuhair Allebban, N. Wong, Sharon Sklar, Renee Bess, M. Spence, H. Pershadsingh, R. Detrano (2010)
Do differences in subclinical cardiovascular disease in mexican americans versus European americans help explain the Hispanic paradox?The American journal of cardiology, 105 2
T. Alves, J. Lewis (2011)
Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma.Clinical nephrology, 74 Suppl 1
Jackson Jr, Y. Lacourciére, R. Samuel, D. Zappe, D. Purkayastha, H. Black (2010)
24‐Hour Ambulatory Blood Pressure Response to Combination Valsartan/Hydrochlorothiazide and Amlodipine/Hydrochlorothiazide in Stage 2 Hypertension by Ethnicity: The EVALUATE StudyThe Journal of Clinical Hypertension, 12
(2006)
Hypertension-related mortality among Hispanic subpopulations--United States, 1995-2002.MMWR. Morbidity and mortality weekly report, 55 7
L. Morgenstern, Melinda Smith, L. Lisabeth, J. Risser, K. Uchino, N. Garcia, P. Longwell, D. McFarling, Olubumi Akuwumi, A. Al-Wabil, Fahmi Al-Senani, Devin Brown, L. Moye (2004)
Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project.American journal of epidemiology, 160 4
C. Herrera, A. Lewin, Robert Fiddes, J. Friedman, W. Linn, T. Baker, Diane Balanoff, C. Beach (1997)
Long‐Acting Diltiazem CD Is Safe and Effective in a Hypertensive Mexican‐American PopulationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 17
S. Stewart, M. Silverstein (2002)
Racial and ethnic disparity in blood pressure and cholesterol measurementJournal of General Internal Medicine, 17
N. Fuenmayor, B. Faggin, L. Cubeddu (2012)
Comparative Efficacy, Safety and Pharmacokinetics of Verapamil SR vs Verapamil IR in Hypertensive PatientsDrugs, 44
V. Roger, A. Go, D. Lloyd‐Jones, E. Benjamin, J. Berry, W. Borden, D. Bravata, S. Dai, E. Ford, C. Fox, H. Fullerton, C. Gillespie, S. Hailpern, J. Heit, V. Howard, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, D. Makuc, G. Marcus, A. Marelli, D. Matchar, C. Moy, D. Mozaffarian, M. Mussolino, G. Nichol, N. Paynter, E. Soliman, P. Sorlie, N. Sotoodehnia, T. Turan, S. Virani, N. Wong, D. Woo, M. Turner (2012)
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.Circulation, 125 1
Hispanics are the fastest growing ethnic minority in the USA. Among Hispanics, lack of hypertension awareness and lack of effective blood pressure (BP) control are problematic, as are higher incidence rates of hypertension-related co-morbidities compared with non-Hispanic populations. Moreover, there are currently no hypertension treatment guidelines that address the unique characteristics of this ethnic group. This article discusses ethnic differences in hypertension and cardiovascular risk factors and reviews the literature on the efficacy of antihypertensive agents in Hispanic patients, with a focus on the role of renin-angiotensinaldosterone system (RAAS) inhibition in the management of hypertension in these patients. Hypertension in Hispanic patients can be challenging to manage, in part because this population has a higher prevalence of obesity, diabetes, and metabolic syndrome compared with non-Hispanic whites. The presence of these comorbidities suggests that RAAS-inhibitor-based therapies may be particularly beneficial in this population. However, few studies have evaluated the efficacy of antihypertensive treatments in Hispanic patients. Two outcomes studies in hypertensive patients have shown the benefits of treating Hispanic patients with antihypertensive therapy and included RAAS inhibitors as part of the treatment regimen. In addition, BP-lowering trials have shown the antihypertensive efficacy of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors, although data on the latter are more limited. Additional studies are needed to more thoroughly evaluate the effects of RAAS inhibitors (and other drug classes) on outcomes and BP lowering in the Hispanic hypertensive population.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Dec 12, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.